Top Markets
Coin of the day
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Rang in Aktien #41696
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-11-07
Marktkapitalisierung
$12.63K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel InNexus Biotechnology, Inc. (IXSBF)

Kategorie

Kursverlauf für InNexus Biotechnology, Inc. (IXSBF)
Höchster Schlusskurs: $0.00 am 2025-11-01

Niedrigster Schlusskurs: $0.54 am 2005-01-01
Kursverlauf der Aktie von InNexus Biotechnology, Inc. von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 0.00%
2024 9,900.00%
2023 -98.02%
2022 -49.50%
2021 809.09%
2020 1,000.00%
2019 -99.00%
2018 0.00%
2017 0.00%
2016 20.00%
2015 -89.80%
2014 45.43%
2013 -9.43%
2012 -75.12%
2011 -93.68%
2010 -30.02%
2009 -1.01%
2008 -76.04%
2007 -65.32%
2006 182.90%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US